A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: Study protocol for a randomized controlled trial

E. Marc Jolicœur, Shmuel Banai, Timothy D. Henry, Marc Schwartz, Serge Doucet, Christopher J. White, Elazer Edelman, Stefan Verheye

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: Study protocol for a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences